Actively Recruiting
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Led by Scynexis, Inc. · Updated on 2024-07-17
100
Participants Needed
1
Research Sites
378 weeks
Total Duration
On this page
Sponsors
S
Scynexis, Inc.
Lead Sponsor
A
AWINSA
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an ongoing evaluation of subjects exposed to ibrexafungerp while pregnant. The study population will include pregnant women of any age.
CONDITIONS
Official Title
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Exposure to ibrexafungerp during pregnancy or conception within 4 days of last dose
- Subject and/or parent/legal representative consents to participate and agrees to study conditions
- Pregnancy confirmed by positive urine pregnancy test if self-reported
- Enrollment can be done by the woman herself or her healthcare provider with consent
You will not qualify if you...
- Females not exposed to ibrexafungerp during pregnancy
- Refusal to participate in the study
- Inability to provide accurate medical history or give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AWINSA
New Delhi, Vasant Vihar, India, 110057
Actively Recruiting
Research Team
S
Sanjeev Miglani, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here